New England Journal Of Medicine Reports Avandia Increases Heart Attack Risk By 43%
The New England Journal of Medicine reported on May 21, 2007 that using Avandia, a drug prescribed for diabetics, increases the risk of a heart attack by 43%. Avandia has been on the market since 1999 and is prescribed to nearly 6 million people worldwid
FDA To Hear Glaxo's Findings on Avandia
The FDA will hear GlaxoSmithKline's findings on the drug Avandia on July 30, 2007. The drug has come under fire for reportedly increasing the risk of heart attacks to those who use it.
Panel Advises FDA to Keep Avandia on Shelves
An advisory committee has recommended that the FDA keep the diabetes drug, Avandia, on the market with increased warnings until further research can be done.
Study Provides Further Proof of Avandias Heart Risks
A new Canadian study conducted by an independent firm recently reported that patients taking the popular diabetes drug, Avandia, had a higher incidence of heart attacks, death and congestive heart failure.
Avandia Being Dropped By Major Pharmacies
Avandia, the popular medication for Type 2 diabetes, is being dropped by at least two major pharmaceutical companies - a further sign that the drug's reported increase of heart risk may be taking its toll.
AAFDA Claims Glaxo Withheld Avandia Studies
The U.S. Food and Drug Administration (FDA) claims that GlaxoSmithKline, PLC withheld nine studies related to Avandia, its popular diabetes drug, after an inspection of the company's North Carolina offices. Research has linked Avandia to a significant i
Consumer Group Says GlaxoSmithKline's Avandia Should Be Banned
The consumer group Public Citizen says that Avandia, GlaxoSmithKline's popular medication for Type 2 diabetes, should be banned as more and more cases of liver toxicity are being linked to the drug's use.
University Study Reports Avandia & Actos Double The Risk Of Bone Fractures
A new medical university study has reported that women who take GlaxoSmithKline's Avandia or Takeda Pharmaceutical's Actos, both drugs which treat Type 2 diabetes, could double their risk of bone fractures. Results of the study are not good news for the two manufacturers who already face numerous lawsuits over the drugs.
Study Links Glitazone Diabetes Drugs Avandia & Actos To Severe Vision Problems
A new study in the April 2009 issue of the American Journal of Ophthalmology (AJO) has linked a group of glitazone diabetes drugs to an increased risk of developing diabetic macular edema, or DME. Popular diabetes drugs such as Avandia and Actos are two of those drugs who have seen their share of problems over the past few years.
New Study Shows Senior Avandia Patients At Greater Risk Of Heart Failure & Deat
A new study by the Canada's Ontario Ministry of Health & Long Term Care published in the British Medical Journal shows that senior patients taking GlaxoSmithKline's diabetes drug Avandia (rosiglitazone) were at a greater risk of heart failure or death than those taking Takeda Pharmaceutical's Actos (pioglitazone) - although both Type 2 diabetes drugs are the subject of hundreds of product liability lawsuits - some of which allege diabetic macular edema, liver toxicity, bone fractures and cardiovascular risks.